| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454827 | Lung Cancer | 2015 | 5 Pages |
Abstract
Rosiglitazone exerted a protective effect on normal tissues in radiation-induced pulmonary injury, while irradiated lung cancer cells were not protected in vivo and in vitro. Thus, rosiglitazone could be proposed as a radioprotective agent in the treatment of lung cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Monica Mangoni, Mariangela Sottili, Chiara Gerini, Pierluigi Bonomo, Anna Bottoncetti, Francesca Castiglione, Ciro Franzese, Sara Cassani, Daniela Greto, Tatiana Masoni, Icro Meattini, Stefania Pallotta, Alessandro Passeri, Alberto Pupi, Eleonora Vanzi,